Literature DB >> 25189793

Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.

Kenji Hashimoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25189793     DOI： 10.1007/s00213-014-3735-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  14 in total

1.  Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.

Authors:  Motoko Maekawa; Tetsuo Ohnishi; Kenji Hashimoto; Akiko Watanabe; Yoshimi Iwayama; Hisako Ohba; Eiji Hattori; Kazuo Yamada; Takeo Yoshikawa
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

Review 2.  Emerging role of glutamate in the pathophysiology of major depressive disorder.

Authors:  Kenji Hashimoto
Journal:  Brain Res Rev       Date:  2009-05-28

3.  The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.

Authors:  Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

4.  Rapid antidepressant effects and abuse liability of ketamine.

Authors:  Chun Yang; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2014-03-26       Impact factor: 4.530

5.  Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.

Authors:  Kazuo Yamada; Tetsuo Ohnishi; Kenji Hashimoto; Hisako Ohba; Yoshimi Iwayama-Shigeno; Manabu Toyoshima; Akira Okuno; Hitomi Takao; Tomoko Toyota; Yoshio Minabe; Kazuhiko Nakamura; Eiji Shimizu; Masanari Itokawa; Norio Mori; Masaomi Iyo; Takeo Yoshikawa
Journal:  Biol Psychiatry       Date:  2005-06-15       Impact factor: 13.382

6.  Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

Authors:  Carlos A Zarate; Nancy Brutsche; Gonzalo Laje; David A Luckenbaugh; Swarajya L Vattem Venkata; Anuradha Ramamoorthy; Ruin Moaddel; Irving W Wainer
Journal:  Biol Psychiatry       Date:  2012-04-18       Impact factor: 13.382

7.  Increased levels of glutamate in brains from patients with mood disorders.

Authors:  Kenji Hashimoto; Akira Sawa; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2007-06-15       Impact factor: 13.382

8.  D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.

Authors:  Ruin Moaddel; David A Luckenbaugh; Ying Xie; Alma Villaseñor; Nancy E Brutsche; Rodrigo Machado-Vieira; Anuradha Ramamoorthy; Maria Paz Lorenzo; Antonia Garcia; Michel Bernier; Marc C Torjman; Coral Barbas; Carlos A Zarate; Irving W Wainer
Journal:  Psychopharmacology (Berl)       Date:  2014-07-24       Impact factor: 4.530

Review 9.  Roles of l-serine and sphingolipid synthesis in brain development and neuronal survival.

Authors:  Yoshio Hirabayashi; Shigeki Furuya
Journal:  Prog Lipid Res       Date:  2008-02-15       Impact factor: 16.195

10.  Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

Authors:  Kenji Hashimoto; Takeshi Fukushima; Eiji Shimizu; Naoya Komatsu; Hiroyuki Watanabe; Naoyuki Shinoda; Michiko Nakazato; Chikara Kumakiri; Shin-ichi Okada; Hisanori Hasegawa; Kazuhiro Imai; Masaomi Iyo
Journal:  Arch Gen Psychiatry       Date:  2003-06
View more
  6 in total

1.  Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-12       Impact factor: 5.270

Review 2.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

3.  Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine.

Authors:  Min Ma; Qian Ren; Yuko Fujita; Chun Yang; Chao Dong; Yuta Ohgi; Takashi Futamura; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2017-07-26       Impact factor: 4.530

Review 4.  An Overview of Animal Models Related to Schizophrenia.

Authors:  Ian R Winship; Serdar M Dursun; Glen B Baker; Priscila A Balista; Ludmyla Kandratavicius; Joao Paulo Maia-de-Oliveira; Jaime Hallak; John G Howland
Journal:  Can J Psychiatry       Date:  2018-05-09       Impact factor: 4.356

Review 5.  Inflammatory biomarkers as differential predictors of antidepressant response.

Authors:  Kenji Hashimoto
Journal:  Int J Mol Sci       Date:  2015-04-08       Impact factor: 5.923

6.  Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.

Authors:  Dmitriy Matveychuk; Rejish K Thomas; Jennifer Swainson; Atul Khullar; Mary-Anne MacKay; Glen B Baker; Serdar M Dursun
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.